title: ASCO 2011: broadening the horizons of cancer research.
authors.forename: Kristine
authors.initials: K
authors.lastname: Crane
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001549:Benzamides; D049109:Cell Proliferation; D004195:Disease Models, Animal; D014943:Global Health; D006801:Humans; D000068877:Imatinib Mesylate; D008495:Medical Oncology / Q000639:trends*; D051379:Mice; D009369:Neoplasms / Q000188:drug therapy* / Q000453:epidemiology / Q000378:metabolism; D014411:Neoplastic Stem Cells / Q000187:drug effects / Q000378:metabolism; D010879:Piperazines / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000187:drug effects; D012106:Research / Q000639:trends*; D012955:Societies, Medical; D000068878:Trastuzumab; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D001549:Benzamides; D000068877:Imatinib Mesylate; D010879:Piperazines; D011743:Pyrimidines; D018719:Erb-b2 Receptor Tyrosine Kinases; D000068878:Trastuzumab; C508053:ERBB2 protein, human